To assess knowledge and self-care practices about Diabetes among patients with type 2 Diabetes Mellitus attending selected tertiary health care institutions. Methods: Cross-sectional study was conducted to assess the knowledge and self-care practices about Diabetes among diagnosed Type 2 Diabetes Mellitus patients attending the outpatient facilities of Medicine Department at selected tertiary healthcare institutions of Udupi Taluk. The data collection occurred from January to March 2017. A total of 166 participants were included in the study and they were selected using consecutive sampling. Knowledge about Diabetes Mellitus was assessed using structured pre-tested questionnaire. Diabetes Self-Management Questionnaire-Revised version was used to assess self-care practices regarding Diabetes Mellitus. Results: Most of the participants (> 65%) had knowledge about different aspects of Diabetes. The Mean total score of self-care practices among participants without and with intensive insulin treatment was 6.25 ± 1.25SD and 6.20 ± 1.01SD respectively. Mean subscales score related to dietary control, glucose management and physician contact was almost the same as that of total mean scale score except for physical activity subscale score in both the group of patients. Conclusion: This study emphasizes the need to strengthen the initiatives related to generating awareness about diabetes and improving self-care practices related to it.
Type 2 diabetes mellitus is a metabolic disorder that occurs due to an interplay of multiple perplexing pathophysiological mechanisms and leads to hyperglycemia. However, till date there has been no single unique molecule that can by itself effectively address all the metabolic abnormalities occurring in type 2 diabetes. Furthermore, type 2 diabetes must be managed with agents that can combat hyperglycemia without causing hypoglycemia and adverse cardiovascular outcomes. Thus, the need of the hour is for a unique molecule that can deliver beyond glycemic control and can in addition address the cardiovascular risk factors that arise in type 2 diabetes. Sodium glucose cotransporter-2 (SGLT-2) inhibitors are the latest of the oral hypoglycemic agents that act by insulin-independent mechanisms and tackle several cardiovascular risk factors that occur in type 2 diabetes. The scope of this article will be to focus primarily on the cardiovascular benefits of SGLT-2 inhibitors and its actions beyond glycemic control in providing a comprehensive care in the management of type 2 diabetes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.